|1.||Rybicki, Benjamin A: 3 articles (08/2013 - 09/2007)|
|2.||Tang, Deliang: 3 articles (08/2013 - 09/2007)|
|3.||Shirai, Tomoyuki: 3 articles (08/2013 - 04/2002)|
|4.||Rundle, Andrew: 3 articles (08/2013 - 09/2007)|
|5.||Takahashi, Satoru: 2 articles (08/2013 - 10/2011)|
|6.||Bock, Cathryn H: 2 articles (10/2011 - 09/2007)|
|7.||Savera, Adnan T: 2 articles (10/2011 - 09/2007)|
|8.||Neslund-Dudas, Christine: 2 articles (10/2011 - 09/2007)|
|9.||Nock, Nora L: 2 articles (10/2011 - 09/2007)|
|10.||Kryvenko, Oleksandr N: 1 article (08/2013)|
|1.||Prostatic Neoplasms (Prostate Cancer)
10/01/2011 - "In this study, we expanded our investigation to estimate the associations between beverage consumption and PhIP-DNA adduct levels in prostate for 391 prostate cancer cases. "
08/15/2013 - "However, our data show that White men have higher PhIP-DNA adduct levels in benign prostate tissue than African American men, and suggest that in certain subgroups of White men high PhIP-DNA adduct levels may predispose to an increased risk for prostate cancer."
08/15/2013 - "Prostate cancer risk for men in the highest quartile of PhIP-DNA adduct levels was modestly increased [odds ratio (OR) = 1.25; 95% confidence interval (CI) = 0.76-2.07]. "
08/15/2013 - "PhIP-DNA adduct levels were measured in specimens from 534 prostate cancer case-control pairs nested within a historical cohort of men with histopathologically benign prostate specimens. "
09/15/2007 - "To determine the clinical and demographic factors associated with PhIP-DNA adduct levels, the biologically effective dose of PhIP in human prostate, we immunohistochemically measured PhIP-DNA adducts in a study of 162 Caucasian and 102 African-American men who underwent radical prostatectomy for prostate cancer. "
10/01/2011 - "Of the 15 beverages analyzed, red wine consumption had the strongest association with PhIP-DNA adduct levels showing an inverse correlation in both tumor (P = 0.006) and nontumor (P = 0.002) prostate cells. "
09/15/2007 - "Race was not associated with PhIP-DNA adduct levels in either tumor or non-tumor cells, but race-specific associations were observed. "
09/15/2007 - "A strong correlation between PhIP-DNA adduct levels in prostate tumor and adjacent non-tumor cells was observed (rho = 0.62; p < 0.0001); however, non-tumor cells had significantly higher adduct levels compared with tumor (0.167 optical density (OD) units +/- 0.043 vs. 0.104 OD +/- 0.027; p < 0.0001). "
08/15/2013 - "In Whites, cancer risk associated with high-grade prostatic intraepithelial neoplasia combined with elevated PhIP-DNA adduct levels (OR = 3.89; 95% CI = 1.56-9.73) was greater than risk associated with either factor alone. "
09/15/2007 - "In conclusion, while PhIP-DNA adduct levels in prostate cells do not vary significantly by race, our results suggest that PhIP exposure may have stronger effects on prostate tumor differentiation in African-American men."
|3.||Prostatic Intraepithelial Neoplasia
|4.||Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/10/2005 - "We have previously shown that C57BL/6J-Min/+ (multiple intestinal neoplasia) mice, heterozygous for the Min mutation in the adenomatous polyposis coli gene, were more susceptible to intestinal tumorigenesis and had higher intestinal PhIP-DNA adduct levels after exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) on day 12 than on day 36 after birth [I.-L. "
|5.||Breast Neoplasms (Breast Cancer)
|1.||2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridine
|1.||Prostatectomy (Retropubic Prostatectomy)